Real-world experience with apremilast in treating psoriasis
JN Mayba, MJ Gooderham - Journal of cutaneous medicine …, 2017 - journals.sagepub.com
Background: Clinical trial data have shown apremilast, an oral phosphodiesterase-4
inhibitor, to be efficacious and safe for the treatment of psoriasis. However, little real-world …
inhibitor, to be efficacious and safe for the treatment of psoriasis. However, little real-world …
Real-World Experience With Apremilast in Treating Psoriasis.
JN Mayba, MJ Gooderham - Journal of Cutaneous Medicine and …, 2016 - europepmc.org
Background Clinical trial data have shown apremilast, an oral phosphodiesterase-4
inhibitor, to be efficacious and safe for the treatment of psoriasis. However, little real-world …
inhibitor, to be efficacious and safe for the treatment of psoriasis. However, little real-world …
Real-World Experience With Apremilast in Treating Psoriasis
JN Mayba, MJ Gooderham - Journal of cutaneous …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Clinical trial data have shown apremilast, an oral phosphodiesterase-4
inhibitor, to be efficacious and safe for the treatment of psoriasis. However, little real-world …
inhibitor, to be efficacious and safe for the treatment of psoriasis. However, little real-world …
Real-World Experience With Apremilast in Treating Psoriasis
JN Mayba, MJ Gooderham - Journal of Cutaneous Medicine and Surgery, 2016 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> Clinical trial data have shown
apremilast, an oral phosphodiesterase-4 inhibitor, to be efficacious and safe for the …
apremilast, an oral phosphodiesterase-4 inhibitor, to be efficacious and safe for the …